Evidence of clinically relevant beta cell graft function up to 60 months [clinicaltrials_resource:662d7c63342ea19ab9da58a569a8b432]
Two clinical implants in the liver:
First implant: ATG-fresenium Maintained immunosuppression: MMF-TAC n=30
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Evidence of clinically relevant beta cell graft function up to 60 months [clinicaltrials_resource:662d7c63342ea19ab9da58a569a8b432]
Two clinical implants in the liver:
First implant: ATG-fresenium Maintained immunosuppression: MMF-TAC n=30
Bio2RDF identifier
662d7c63342ea19ab9da58a569a8b432
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:662d7c63342ea19ab9da58a569a8b432
measure [clinicaltrials_vocabulary:measure]
Evidence of clinically relevant beta cell graft function
time frame [clinicaltrials_vocabulary:time-frame]
up to 60 months
description
Two clinical implants in the l ...... mmunosuppression: MMF-TAC n=30
identifier
clinicaltrials_resource:662d7c63342ea19ab9da58a569a8b432
title
Evidence of clinically relevant beta cell graft function up to 60 months
@en
type
label
Evidence of clinically relevan ...... d7c63342ea19ab9da58a569a8b432]
@en